col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


43 Results       Page 1

 [1] 
Springer (Biomed Central Ltd.): Journal of Genetic Engineering and Biotechnology
  original article Date Title Authors   All Authors
1 [GO] 2025―Dec―24 Association of gender and main comorbidities with expression of lncRNAs and mRNAs in COVID-19 patients Hassan Abolghasemi, Hamidreza Kheiri, Hamid Sedighian, Elham Behzadi, Reza Kachuei, Mozhgan Kheirandish, et al. (+2)
2 [GO] 2025―Jun―21 An immunoinformatics approach in designing high-coverage mRNA multi-epitope vaccine against multivariant SARS-CoV-2 Ernawati Arifin Giri-Rachman, Al Mirahma Febri Kurnianti, Aditya Hanung Setyadi, Anita Artarini, Marselina Irasonia Tan, Catur Riani, et al. (+3)
3 [GO] 2025―Jun―17 Profiling of proteases involved in SARS-CoV-2 pathogenesis in human saliva: Influence of age and gender Mentalla Motaz Abdellatif, Azza El Amir, Said Shalaby, Michael Kirschfink, Rola Nadeem, Dina Nadeem Abd-Elshafy, Mahmoud Mohamed Bahgat
4 [GO] 2025―Mar―04 MEFV gene variations in COVID-19 pneumonia patients (Pilot study) Noha A. Radwan, Heba El Gohary, Dalia Hamed, Noha M. Khalil, Dalia Abdelfatah, Amal Abdel Wahab, Marwa Mahmoud Elsharkawy
5 [GO] 2024―Nov―16 Exploring advanced genomic and immunoinformatics techniques for identifying drug and vaccine targets against SARS-CoV-2 Syed Luqman Ali, Awais Ali, Waseef Ullah, Abdulaziz Alamri, Elham Mohammed Khatrawi, Gulzira Sagimova, et al. (+6)
6 [GO] 2024―Nov―14 Association of plasma microRNAs with COVID-19 severity and outcome Sohair Salem, Randa Lotfy, Noha Eltaweel, Mohamed Elbadry
7 [GO] 2024―Aug―02 Can human IgG subclasses distinguish between confirmed and unconfirmed SARS-CoV-2 infections? Mahmoud Mohamed Bahgat, Mohamed Hassan Nasraa, Rola Nadeem, Khaled Amer, Wael A. Hassan, Ahmed Abd EL-Raouf, Dina Nadeem Abd-Elshafy
8 [GO] 2024―Jan―23 Emergence of carbapenem resistant gram-negative pathogens with high rate of colistin resistance in Egypt: A cross sectional study to assess resistance trends during the COVID-19 pandemic Fatma A. Afify, Ahmed H. Shata, Nirmeen Aboelnaga, Dina Osama, Salma W. Elsayed, Nehal A. Saif, et al. (+5)
9 [GO] 2024―Jan―22 SARS-CoV-2 Omicron Spike shows strong binding affinity and favourable interaction landscape with the TLR4/MD2 compared to other variants Chiranjib Chakraborty, Bidyut Mallick, Manojit Bhattacharya, Siddappa N. Byrareddy
10 [GO] 2023―Dec―18 Reverse transcription loop-mediated isothermal amplification (RT-LAMP) primer design based on Indonesia SARS-CoV-2 RNA sequence Irsyad Ibadurrahman
11 [GO] 2023―Nov―15 Computational design and evaluation of mRNA- and protein-based conjugate vaccines for influenza A and SARS-CoV-2 viruses Amir Elalouf, Tomer Kedarya, Hadas Elalouf, Ariel Rosenfeld
12 [GO] 2023―Nov―13 Prognostic significance of serum miR-18a-5p in severe COVID-19 Egyptian patients Riham Abdel-Hamid Haroun, Waleed H. Osman, Asmaa M. Eessa
13 [GO] 2023―Oct―06 Porphyrin-derived carbon dots for an enhanced antiviral activity targeting the CTD of SARS-CoV-2 nucleocapsid Azzania Fibriani, Audrey Angelina Putri Taharuddin, Nicholas Yamahoki, Rebecca Stephanie, Jessica Laurelia, Dian Fitria Agustiyanti, et al. (+9)
14 [GO] 2023―May―21 Potential role of PIM1 inhibition in the treatment of SARS-CoV-2 infection Magda M. F. Ismail, Rehab R. El-Awady, Amal M. Farrag, Sara H. Mahmoud, Noura M. Abo Shama, Ahmed Mostafa, et al. (+3)
15 [GO] 2023―Mar―20 Insights on the interaction of SARS-CoV-2 variant B.1.617.2 with antibody CR3022 and analysis of antibody resistance Sandhya KS, Achuthsankar S. Nair
16 [GO] 2023―Feb―09 Baculovirus displaying SARS-CoV-2 spike RBD promotes neutralizing antibody production in a mouse model Mohamed A. Wahba, Dina Mofed, Doaa A. Ghareeb, Jihad I. Omran, Tamer Z. Salem
17 [GO] 2022―Nov―01 A multi-population-based genomic analysis uncovers unique haplotype variants and crucial mutant genes in SARS-CoV-2 Afzal Sheikh, He Huang, Sultana Parvin, Mohammad Badruzzaman, Tofayel Ahamed, Ekhtear Hossain, et al. (+2)
18 [GO] 2022―Sep―20 Immunoinformatics approach to epitope-based vaccine design against the SARS-CoV-2 in Bangladeshi patients Shahina Akter, Muhammad Shahab, Md. Murshed Hasan Sarkar, Chandni Hayat, Tanjina Akhtar Banu, Barna Goswami, et al. (+6)
19 [GO] 2022―Sep―06 An in silico pipeline approach uncovers a potentially intricate network involving spike SARS-CoV-2 RNA, RNA vaccines, host RNA-binding proteins (RBPs), and host miRNAs at the cellular level Massimiliano Chetta, Marina Tarsitano, Maria Oro, Maria Rivieccio, Nenad Bukvic
20 [GO] 2022―Jul―18 Molecular docking and identification of G-protein-coupled receptor 120 (GPR120) agonists as SARS COVID-19 MPro inhibitors Sellappan Mohan, Jayagopal Dharani, Ramanathan Natarajan, Arumugam Nagarajan
21 [GO] 2022―Jul―13 The consequences of viral infection on host DNA damage response: a focus on SARS-CoVs Asmaa S. Mekawy, Zina Alaswad, Aya A. Ibrahim, Ahmed A. Mohamed, Abdelrahman AlOkda, Menattallah Elserafy
22 [GO] 2022―Jul―06 Application of Baculovirus Expression Vector system (BEV) for COVID-19 diagnostics and therapeutics: a review Muhammad Azharuddin Azali, Salmah Mohamed, Azian Harun, Faezahtul Arbaeyah Hussain, Shaharum Shamsuddin, Muhammad Farid Johan
23 [GO] 2022―Jun―17 QSAR, homology modeling, and docking simulation on SARS-CoV-2 and pseudomonas aeruginosa inhibitors, ADMET, and molecular dynamic simulations to find a possible oral lead candidate Emmanuel Israel Edache, Adamu Uzairu, Paul Andrew Mamza, Gideon Adamu Shallangwa
24 [GO] 2022―May―24 A review on drug repurposing in COVID-19: from antiviral drugs to herbal alternatives Abas Sezer, Mervisa Halilović-Alihodžić, Annissa Rachel Vanwieren, Adna Smajkan, Amina Karić, Husein Djedović, Jasmin Šutković
25 [GO] 2022―May―11 Genome sequencing reveals existence of SARS-CoV-2 B.1.1.529 variant in Egypt Ghada Ismail, Hossam Abdelghaffar, Mohamed G. Seadawy, Mostafa F. El-Hosseny, Ahmed F. Gad, Amr Ageez, et al. (+4)
26 [GO] 2022―May―09 Correction: Immunoinformatics approach of epitope prediction for SARS-CoV-2 Nourelislam Awad, Rania Hassan Mohamed, Nehal I. Ghoneim, Ahmed O. Elmehrath, Nagwa El-Badri
27 [GO] 2022―Apr―28 Design of siRNA molecules for silencing of membrane glycoprotein, nucleocapsid phosphoprotein, and surface glycoprotein genes of SARS-CoV2 Vijaya Sai Ayyagari
28 [GO] 2022―Apr―20 Immunoinformatics approach of epitope prediction for SARS-CoV-2 Nourelislam Awad, Rania Hassan Mohamed, Nehal I. Ghoneim, Ahmed O. Elmehrath, Nagwa El-Badri
29 [GO] 2022―Apr―14 Molecular docking unveils the potential of andrographolide derivatives against COVID-19: an in silico approach Ravichandran Veerasamy, Rohini Karunakaran
30 [GO] 2022―Mar―09 In silico discovery of 3 novel quercetin derivatives against papain-like protease, spike protein, and 3C-like protease of SARS-CoV-2 Kunal Bhattacharya, Ripunjoy Bordoloi, Nongmaithem Randhoni Chanu, Ramen Kalita, Bhargab Jyoti Sahariah, Atanu Bhattacharjee
31 [GO] 2022―Jan―14 Immunity evasion: consequence of the N501Y mutation of the SARS-CoV-2 spike glycoprotein Henrietta Onyinye Uzoeto, Judith Nnedimkpa Ajima, Amarachukwu Vivian Arazu, Glory Omini Ibiang, Samuel Cosmas, Olanrewaju Ayodeji Durojaye
32 [GO] 2021―Nov―09 Molecular docking and pharmacokinetic studies of phytocompounds from Nigerian Medicinal Plants as promising inhibitory agents against SARS-CoV-2 methyltransferase (nsp16) Tolulope Peter Saliu, Haruna I. Umar, Olawale Johnson Ogunsile, Micheal O. Okpara, Noriyuki Yanaka, Olusola Olalekan Elekofehinti
33 [GO] 2021―Oct―22 The potential role of inhaled nitric oxide for postexposure chemoprophylaxis of COVID-19 Antoine AbdelMassih, Rafeef Hozaien, Meryam El Shershaby, Aya Kamel, Habiba-Allah Ismail, Mariem Arsanyous, et al. (+4)
34 [GO] 2021―Sep―20 Analysing the impact of the two most common SARS-CoV-2 nucleocapsid protein variants on interactions with membrane protein in silico Syeda Tasnim Quayum, Saam Hasan
35 [GO] 2021―Aug―05 SARS-CoV-2 host cell entry: an in silico investigation of potential inhibitory roles of terpenoids Gideon A. Gyebi, Oludare M. Ogunyemi, Ibrahim M. Ibrahim, Olalekan B. Ogunro, Adegbenro P. Adegunloye, Saheed O. Afolabi
36 [GO] 2021―Jul―16 Anti-HIV reverse transcriptase plant polyphenolic natural products with in silico inhibitory properties on seven non-structural proteins vital in SARS-CoV-2 pathogenesis Von Novi O. de Leon, Joe Anthony H. Manzano, Delfin Yñigo H. Pilapil, Rey Arturo T. Fernandez, James Kyle Anthony R. Ching, Mark Tristan J. Quimque, et al. (+3)
37 [GO] 2021―Jul―13 Andrographolide binds to spike glycoprotein and RNA-dependent RNA polymerase (NSP12) of SARS-CoV-2 by in silico approach: a probable molecule in the development of anti-coronaviral drug Lokanathan Srikanth, Potukuchi Venkata Gurunadha Krishna Sarma
38 [GO] 2021―Jun―04 PPAR agonists as effective adjuvants for COVID-19 vaccines, by modifying immunogenetics: a review of literature Antoine Fakhry AbdelMassih, Rahma Menshawey, Jumana H. Ismail, Reem J. Husseiny, Yousef M. Husseiny, Shenoda Yacoub, et al. (+55)
39 [GO] 2021―Apr―02 Novel mutations in NSP-1 and PLPro of SARS-CoV-2 NIB-1 genome mount for effective therapeutics Mohammad Uzzal Hossain, Arittra Bhattacharjee, Md. Tabassum Hossain Emon, Zeshan Mahmud Chowdhury, Ishtiaque Ahammad, Md. Golam Mosaib, et al. (+9)
40 [GO] 2021―Jan―25 Molecular docking studies of some selected gallic acid derivatives against five non-structural proteins of novel coronavirus Haruna Isiyaku Umar, Bushra Siraj, Adeola Ajayi, Tajudeen O. Jimoh, Prosper Obed Chukwuemeka
41 [GO] 2020―Nov―27 Molecular docking and simulation investigation: effect of beta-sesquiphellandrene with ionic integration on SARS-CoV2 and SFTS viruses Amit Joshi, G. Sunil Krishnan, Vikas Kaushik
42 [GO] 2020―Nov―03 A comprehensive review on promising anti-viral therapeutic candidates identified against main protease from SARS-CoV-2 through various computational methods Ekampreet Singh, Rameez Jabeer Khan, Rajat Kumar Jha, Gizachew Muluneh Amera, Monika Jain, Rashmi Prabha Singh, et al. (+2)
43 [GO] 2020―Jul―28 Drug repurposing of nitazoxanide: can it be an effective therapy for COVID-19? Dina B. Mahmoud, Zayyanu Shitu, Ahmed Mostafa
 [1] 

43 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.005 sec